INTRODUCTION
Vision loss associated with intraocular silicone oil (SiO) tamponade may be the result of various factors, such as optic neuropathy and retinal toxicity, although the exact pathophysiology remains unclear. [1] [2] [3] [4] [5] Histopathologic studies have correlated the presence of SiO droplets within ocular tissues, including the iris, retina, trabecular meshwork, ciliary body, and epiretinal membranes (ERMs), with associated localized inflammation. 6, 7 Additionally, anterior segment pathology such as glaucoma, cataract, and keratopathy are known complications of prolonged SiO tamponade. [8] [9] [10] The risk for developing SiO-related vision loss or emulsification has been noted to be highly variable among patients and may be dependent upon biologic mediators, surfactants, or contaminants. 11 Due to the preceding factors, and in order to mitigate possible visual sequelae (cataract formation and refractive error), many surgeons generally opt for SiO removal (SOR) between 3 and 6 months post-instillation.
With the advent of spectral-domain optical coherence tomography (SD-OCT), high-resolution in vivo imaging of ocular structures has allowed for further analysis of tissue architecture in relation to various vitreoretinal pathologies. Recently, investigators have used cross-sectional SD-OCT images to demonstrate presence of thinning of the ganglion cell and inner retinal layers in eyes with SiO tamponade, which may be associated with poor functional visual outcomes. [11] [12] [13] Additionally, SD-OCT and swept-source OCT analysis of eyes with SiO tamponade has also revealed the presence of hyperreflective areas located intraretinally and subretinally, which several authors have argued may correlate with possible silicone oil emulsification and deposition. [14] [15] [16] The aim of this study was to further evaluate and characterize structural retinal changes, particularly outer retinal changes, present on SD-OCT in eyes that have undergone pars plana vitrectomy (PPV) with SiO tamponade.
PATIENTS AND METHODS
Institutional review board approval for this retrospective, consecutive case series was obtained through Wills Eye Hospital. Research adhered to the tenets of the Declaration of Helsinki, and was conducted in accordance with regulations set forth by the Health Insurance Portability and Accountability Act.
All charts of patients who had undergone PPV with SiO tamponade for the diagnoses of tractional retinal detachment, proliferative vitreoretinopathy, or rhegmatogenous retinal detachment between July 2010 and December 2014 were initially included for review. We then excluded eyes that had a prior history of SiO endotamponade, trauma, eyes that had re-detached (while under SiO tamponade or post-SOR), or eyes that were aphakic at the time of SiO instillation. Additionally, only patients who had completed SD-OCT (Spectralis; Heidelberg Engineering, Heidelberg, Germany) imaging and visual acuity (VA) measurements during SiO tamponade and post-removal (at a minimum of 1 month after SOR) were included in the study.
The following SD-OCT parameters were recorded: presence of subretinal fluid (SRF), ERM, ellipsoid zone disruption (EZD), external limiting membrane disruption (ELMD), macular hole, central subfield thickness (CST), and choroidal thickness. Fisher's exact test of independence was used to compare the preceding parameters in eyes pre-and post-SOR. The CST was defined as average thickness of the central 1 mm subfield centered at the fovea, obtained from the Spectralis SD-OCT mapping software. Total duration of SiO tamponade was also noted, along with timing of SD-OCT acquisition in relation to placement of SiO tamponade and SOR. VAs with SiO present and post-SOR were recorded. Lens status at time of SiO instillation was documented, along with the incidence of ERM peeling and cataract extraction with intraocular lens placement at the time of SOR based on a review of the operative reports.
Mean values and standard deviations were calculated for the aforementioned parameters. Mean VA was calculated using standard logarithm of the minimum angle of resolution (logMAR) VA converted from the pinhole Snellen VA. 17 Pre-and post-SOR logMAR VA, CST, and choroidal thickness were tested for normality using the Shapiro-Wilk test followed by either the appropriate nonparametric Mann-Whitney test or student's t test.
Patients were then separated into groups based on the presence or absence of SRF or EZD while under SiO tamponade. The Shapiro-Wilk test was used to test the following variables for normality within each group: age, total time of SiO tamponade, CST under SiO tamponade and post-SOR, choroidal thickness under SiO tamponade and post-SOR, and logMAR VA under SiO tamponade and post-SOR (XLStat 2015.5.01; Addinsoft, New York, NY). Nonparametric or parametric testing was then completed using either the MannWhitney test or independent t test, respectively. A P value of less than .05 was deemed significant.
RESULTS
Thirty eyes from 30 patients met all inclusion criteria and were included in the study, and all 30 eyes had complete retinal re-attachment with SiO tamponade. Baseline patient demographics and ocular findings are outlined in Table 1 .
Mean logMAR VA with SiO tamponade was 1.581 ± 0.563 (Snellen equivalent, 20/762) at the 1-month postoperative visit and 1.013 ± 0.73 (Snellen equivalent, 20/206) post-SOR (P < .001). Post-SOR VA measure- Table 3 . A significant difference in VA was found between patients with SRF under SiO tamponade versus those without SRF (Table 3 ; P = .041). Although data did not reach significance, it is notable that the mean time SiO was placed in patients with SRF was 162.8 days ± 62.9 days versus those without SRF was 211.0 days ± 79.5 days (Table 3 ; P = .078). Patients with EZD under SiO were noted to have a significantly longer duration of SiO tamponade (Table 3 ; P = .029), along with a significantly worse visual acuity post-SOR (Table 3 ; P = .002). Of the 10 eyes that had resolution of EZD post-SOR, mean VA was significantly better (Snellen equivalent 20/133) compared to those eyes with persistent EZD (Snellen equivalent 20/513; P = .01). No significant difference was found for time between SD-OCTs for eyes with and without EZD while under SiO tamponade and post-SOR (Table 3 ; P = .453).
DISCUSSION
Visual loss has been previously described to occur in patients both during SiO tamponade and after its removal.
1 Less common causes of visual decline have been hypothesized to result from possible optic neuropathy and/or retinal dysfunction. 18 Some have theorized that SiO toxicity may be related to intracellular accumulation of potassium ions, leading to degeneration of retinal tissue due to inability to filter potassium into the displaced vitreous.
1,2 Other authors have argued that SiO tamponade causes dissolution of photoprotective elements within the retina, disrupting retinal architecture. 19 Similar to previous reports, 20 our analysis showed an increased frequency of SRF along with CME in eyes with SiO endotamponade (Table 2 ). However, our study failed to show a significant difference in length of time SiO was placed in patients who had SRF versus those without SRF (Table 3) . Indeed, patients without SRF had a longer mean time of SiO instillation. These results may be due to a significant difference in time between SiO instillation and SD-OCT completion (84.52 days ± 59.55 days in the SRF group versus 147.60 days ± 76.71 days in the no SRF group; P = .018). Additionally, underlying retinal pathology may have contributed to this difference as a larger number of patients had initial "macula on" status within the group that did not have SRF (four of 15 eyes) versus those that had SRF (one of 15 eyes).
Additionally, our study investigated choroidal thickness on EDI-OCT in patients with SiO endotamponade. Although it did not reach significance, the mean choroidal thickness in patients with SiO tamponade measured greater than post-SOR (P = .07). However, with the inability to control for such factors as age, axial length, refractive error, and time of day of measurements in this retrospective study, it would be unwise to draw any definitive conclusions regarding the effects of SiO instillation on choroidal thickness. However, as increased choroidal thickness has been described to occur in patients with active uveitis or intraocular inflammation, it is possible that the increase in choroidal thickness measurements under SiO parallels an increase in inflammatory markers as suggested by histopathology studies. 7, 21 Our analysis indicated a significant improvement in visual acuity in eyes post-SOR (20/762 and 20/206; P = .001). In addition to elimination of the refractive shift after SOR, this improvement may have resulted from concurrent cataract extraction and/or epiretinal membrane peeling, which was performed in 13 of 30 (43.3%) and 11 of 30 (36.7%) patients, respectively (Table 3) . We also looked at the presence of disruption involving the external limiting membrane and/or ellipsoid zone (Tables 2 and 3) . Notably, total length of SiO tamponade was significantly different in patients with ELMD and EZD present on SD-OCT (220.6 days ± 69.5 days) versus patients without presence of ELMD or EZD (161.1 days ± 70.2 days; P = .029) ( Table 3) . Additionally, patients with presence of ELMD or EZD on SD-OCT prior to SOR had a significantly worse visual acuity after removal (P = .002) (logMAR 1.38 ± 0.73, Snellen equivalent 20/478) than those patients without disruption of these layers on SD-OCT (logMAR 0.76 ± 0.62, Snellen equivalent 20/115) ( Table 3) . Of note, seven out of 10 of the eyes with no EZD versus four out of 20 of the eyes with EZD did undergo ERM peel at the time of silicone oil removal, possibly affecting final visual acuity results (Table 3) . Of the 20 eyes with EZD on SD-OCT while under SiO tamponade, 13 of these eyes did not undergo cataract extraction due to lack of visually significant cataract upon removal of oil. This suggests that outer retinal changes on SD-OCT found while under SiO tamponade might not be due to dense cataract or poor signal strength.
In histologic analyses, retinal thinning in patients with SiO endotamponade has been described as degeneration of the nerve fiber and ganglion cell layers, (10 of 20) under SiO had resolution of this disruption after oil removal, suggesting that this damage may potentially be reversible; a small portion of eyes with improvement of EZD (three of 10) did have concurrent ERM peels at the time of SOR, potentially affecting resolution of outer retinal disruption. These structural changes appear to correlate with clinical outcomes, given the significant improvement in visual acuity in the eyes that had resolution of EZD compared to those with persistent EZD. Another possibility is that resolution of ELMD and EZD may represent the natural course of successful retinal reattachment itself rather than a result of SOR. However, three out of five eyes with initial macula-on status were noted to have both EZD and ELMD on SD-OCT present while under SiO tamponade; all three eyes exhibited resolution of disruption post-SOR (no eyes underwent ERM peel with SOR). These changes may serve to illustrate why visual potential post-SOR remains poor in some patients despite anatomic and surgical success.
Our study has several limitations, particularly as relates to its retrospective case series design. As a result, standardized best-corrected VA testing with protocol refraction as well as standardized SD-OCT timing in relation to SiO instillation and removal was not available. Additionally, given our small sample size and retrospective analysis, controlling for confounding factors such as cataract, epiretinal membrane and varying disease pathology proves difficult. It is possible that patients with more severe disease pathology (eg, prolonged duration of a macula-off RD, worse proliferative vitreoretinopathy, etc.) may have experienced increased macular damage or retinal atrophy due to the underlying disease process itself. As such, those patients may have had a longer duration of SiO tamponade due to surgeon preference, making it difficult to extrapolate whether SD-OCT and clinical findings are due to retinal changes from the natural course of the disease process or from the effects of SiO instillation on retinal architecture and function.
In summary, structural abnormalities of retinal architecture on SD-OCT in SiO-filled eyes appear to improve in some patients following SOR. In patients who have undergone PPV with SiO instillation for various pathologies, the presence of EZD and ELMD on SD-OCT may help explain the poor vision outcomes in some patients after SiO removal despite successful anatomic reattachment. Future prospective studies may help better determine the causal relationship between SiO endotamponade and these structural changes seen on SD-OCT.
